Latest Articles

Publication Date
Potential Immunotherapy After Immunotherapy in Select Endometrial Cancer Populations - CancerNetwork

Potential Immunotherapy After Immunotherapy in Select Endometrial Cancer Populations CancerNetwork

Published: May 21, 2026, 7 p.m.
Endometriosis and ovarian cancer risk.

To critically evaluate the evidence linking endometriosis to ovarian cancer, with particular focus on endometrioid and clear cell histologic subtypes, and to inform risk stratification and patient counseling.

Published: May 12, 2026, midnight
Managing Progression After Immunotherapy in Endometrial Cancer - OncLive

Managing Progression After Immunotherapy in Endometrial Cancer OncLive

Published: May 5, 2026, 12:07 p.m.
High response rates in platinum-resistant ovarian cancer with immunotherapy agents - MSN

High response rates in platinum-resistant ovarian cancer with immunotherapy agents MSN

Published: April 20, 2026, 8:14 a.m.
Impact of Overall Survival Data on Immunotherapy Selection in Endometrial Cancer - Pharmacy Times

Impact of Overall Survival Data on Immunotherapy Selection in Endometrial Cancer Pharmacy Times

Published: April 17, 2026, 12:30 p.m.
High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents - MedPage Today

High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents MedPage Today

Published: April 16, 2026, 7:11 p.m.
Epigenetic Compound Library Screen Identifies Ibrutinib as an Inhibitor of Ovarian Clear Cell Carcinoma Viability.

Ovarian clear cell carcinoma (OCCC) is an endometriosis-associated ovarian cancer subtype. Somatic mutations in OCCC are reported in ARID1A, PIK3CA, and the TERT promoter (TERTp), as well as less commonly …

Published: April 10, 2026, midnight
Endometriosis and Endometrial Cancer-Association Between Biological Mechanisms and Its Clinical Implications.

Endometriosis and endometrial cancer are distinct gynecological conditions that share overlapping biological mechanisms with implications for clinical management. Endometriosis is a chronic, benign disorder characterized by the ectopic implantation of …

Published: April 10, 2026, midnight
CAR-NKT cell therapy offers scalable, off-the-shelf immunotherapy for endometrial carcinoma - Oncology Central

CAR-NKT cell therapy offers scalable, off-the-shelf immunotherapy for endometrial carcinoma Oncology Central

Published: March 23, 2026, 9:45 a.m.
CAR-NKT cell therapy: a scalable immunotherapy option for endometrial carcinoma - Oncology Central

CAR-NKT cell therapy: a scalable immunotherapy option for endometrial carcinoma Oncology Central

Published: March 23, 2026, 9:45 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!